Circumvention of defective neutral amino acid transport in Hartnup disease using tryptophan ethyl ester.
Tryptophan ethyl ester, a lipid-soluble tryptophan derivative, was used to bypass defective gastrointestinal neutral amino acid transport in a child with Hartnup disease. The child's baseline tryptophan concentrations in serum (20 +/- 6 microM) and cerebrospinal fluid (1.0 +/- 0.2 microM) were persi...
Na minha lista:
| Udgivet i: | J Clin Invest |
|---|---|
| Principais autores: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society for Clinical Investigation
1989
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC303970/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2472426/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI114141 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|